Monday, April 26, 2021

X-Biotix Therapeutics Announces Change In Corporate Strategy

 X-Biotix Therapeutics, Inc. (X-Biotix), a biotechnology company focused on the discovery and development of first-in-class antibiotic compounds targeting multi-drug-resistant Gram-negative pathogens, announced today a change in its strategy, which will include suspension of its current antibacterial research efforts. 


Link:

businesswire.com/news/home/20210426005029/en/X-Biotix-Therapeutics-Announces-Change-in-Corporate-Strategy

No comments:

Post a Comment